Amesite Announces Withdrawal of Registration Statement on Form S-1
Rhea-AI Summary
Amesite (NASDAQ: AMST) announced filing with the SEC to withdraw its Registration Statement on Form S-1 (No. 333-295187) filed April 20, 2026, and said it no longer intends to pursue the public offering described in that filing at this time. The Registration Statement was not declared effective and no securities were sold.
The company reiterated its AI healthcare product NurseMagic™, citing a target market of $330 billion and usage claims including reduction of documentation time from 20 minutes to 20 seconds, use by over 100 professions, and deployment across 50 states and 21 countries.
Positive
- No securities were sold under the withdrawn Registration Statement
- NurseMagic reported use across 50 states and 21 countries
- NurseMagic cited reduction in documentation time from 20 minutes to 20 seconds
Negative
- Company withdrew Form S-1 and no longer pursues the planned offering
- Registration Statement was not declared effective by the SEC
News Market Reaction – AMST
On the day this news was published, AMST declined 33.54%, reflecting a significant negative market reaction. Argus tracked a peak move of +32.2% during that session. Argus tracked a trough of -37.7% from its starting point during tracking. Our momentum scanner triggered 23 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $4M from the company's valuation, bringing the market cap to $8.83M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 26 | Connectivity agreement | Positive | +6.4% | HIPAA-compliant integration of NurseMagic EMR with major homecare billing platform. |
| Mar 04 | Award finalist | Positive | -6.2% | NurseMagic named AI nursing tool award finalist alongside revenue acceleration details. |
| Dec 19 | EMR launch | Positive | +17.2% | Launch of AI-native NurseMagic EMR targeting large U.S. post-acute care market. |
| Oct 30 | Revenue update | Positive | -0.8% | Reported 69% QoQ revenue increase in Q2 2026 and outlined AI product roadmap. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news has produced mixed reactions: strong AI and growth updates sometimes led to gains, but similar positive narratives also saw flat-to-negative moves.
Over the last several months, Amesite has focused on scaling its AI-driven NurseMagic™ platform across post-acute care. Prior announcements highlighted rapid revenue growth, including multiple quarters with double-digit QoQ increases and launches such as the AI-native NurseMagic EMR. Market reactions were inconsistent, with some product and growth updates driving gains above 17%, while others saw modest or negative moves. Against this backdrop, today’s withdrawal of the April 20, 2026 S-1 registration removes a potential equity offering overhang while the company continues emphasizing AI healthcare execution and recent growth metrics.
Key Terms
hipaa regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
DETROIT, April 27, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST) (the “Company”), a leading developer of AI-powered enterprise solutions, today announced that it has filed with the U.S. Securities and Exchange Commission (the “SEC”) a request for withdrawal of the Company’s Registration Statement on Form S-1 (No. 333-295187) originally filed on April 20, 2026 (the “Registration Statement”), as the Company no longer intends to pursue a public offering under the Registration Statement at this time. The Registration Statement has not been declared effective by the SEC, and no securities have been sold in connection with the public offering described in the Registration Statement.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of these securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's NurseMagic™ platform, the Company's business plans, any future commercialization of the Company's NurseMagic™ platform, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
